Royal Bank of Canada’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Buy |
3,297
+2,386
| +262% | +$5.07K | ﹤0.01% | 6197 |
|
|
2025
Q1 | $2K | Sell |
911
-948
| -51% | -$2.08K | ﹤0.01% | 6215 |
|
|
2024
Q4 | $5K | Sell |
1,859
-2,642
| -59% | -$7.11K | ﹤0.01% | 6057 |
|
|
2024
Q3 | $14K | Buy |
4,501
+3,420
| +316% | +$10.6K | ﹤0.01% | 5771 |
|
|
2024
Q2 | $4K | Buy |
+1,081
| New | +$4K | ﹤0.01% | 6233 |
|
|
2024
Q1 | – | Sell |
-1,437
| Closed | -$7K | – | 7018 |
|
|
2023
Q4 | $7K | Sell |
1,437
-1,423
| -50% | -$6.93K | ﹤0.01% | 6056 |
|
|
2023
Q3 | $15K | Buy |
2,860
+2,711
| +1,819% | +$14.2K | ﹤0.01% | 5795 |
|
|
2023
Q2 | $0 | Sell |
149
-237
| -61% | – | ﹤0.01% | 7132 |
|
|
2023
Q1 | $1K | Sell |
386
-566
| -59% | -$1.47K | ﹤0.01% | 6551 |
|
|
2022
Q4 | $3K | Buy |
952
+873
| +1,105% | +$2.75K | ﹤0.01% | 6408 |
|
|
2022
Q3 | $0 | Buy |
79
+9
| +13% | – | ﹤0.01% | 7327 |
|
|
2022
Q2 | $2K | Sell |
70
-327
| -82% | -$9.34K | ﹤0.01% | 6538 |
|
|
2022
Q1 | $15K | Sell |
397
-1,056
| -73% | -$39.9K | ﹤0.01% | 6281 |
|
|
2021
Q4 | $85K | Buy |
1,453
+791
| +119% | +$46.3K | ﹤0.01% | 5522 |
|
|
2021
Q3 | $55K | Buy |
662
+224
| +51% | +$18.6K | ﹤0.01% | 5588 |
|
|
2021
Q2 | $41K | Buy |
+438
| New | +$41K | ﹤0.01% | 5678 |
|
|
2020
Q2 | – | Sell |
-7
| Closed | – | – | 6343 |
|
|
2020
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 6346 |
|
|
2019
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 6371 |
|
|
2019
Q3 | $0 | Buy |
+7
| New | – | ﹤0.01% | 6193 |
|